BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19901632)

  • 1. Increasing civil society participation in the national HIV response: the role of UNGASS reporting.
    Peersman G; Ferguson L; Torres MA; Smith S; Gruskin S
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S97-103. PubMed ID: 19901632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the 2001 Declaration of Commitment on HIV/AIDS.
    Warner-Smith M; Rugg D; Frescura L; Moussavi S
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S77-86. PubMed ID: 19901630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports.
    Carael M; Marais H; Polsky J; Mendoza A
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S111-8. PubMed ID: 19901623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are we on course for reporting on the Millennium Development Goals in 2015?
    Rugg D; Marais H; Carael M; De Lay P; Warner-Smith M
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S69-76. PubMed ID: 19901629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
    Mathers BM; Degenhardt L; Adam P; Toskin I; Nashkhoev M; Lyerla R; Rugg D
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S132-42. PubMed ID: 19901626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decade of investments in monitoring the HIV epidemic: how far have we come? A descriptive analysis.
    Alfven T; McDougal L; Frescura L; Aran C; Amler P; Gill W
    Health Res Policy Syst; 2014 Oct; 12():62. PubMed ID: 25322764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding role of civil society in the global HIV/AIDS response: what has the President's Emergency Program For AIDS Relief's role been?
    Coutinho A; Roxo U; Epino H; Muganzi A; Dorward E; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S152-7. PubMed ID: 22797737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human rights and universal access for men who have sex with men and people who inject drugs: a qualitative analysis of the 2010 UNGASS narrative country progress reports.
    Persson A; Ellard J; Newman C; Holt M; de Wit J
    Soc Sci Med; 2011 Aug; 73(3):467-74. PubMed ID: 21764488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rights in the global response to HIV: findings from the 2008 United Nations General Assembly Special Session Reports.
    Gruskin S; Ferguson L; Peersman G; Rugg D
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S104-10. PubMed ID: 19901622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brazilian leadership in the context of the UNGASS Declaration of Commitment in HIV/AIDS].
    Bermúdez XP; Seffner F
    Rev Saude Publica; 2006 Apr; 40 Suppl():101-8. PubMed ID: 16729165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study.
    Rodi P; Obermeyer W; Pablos-Mendez A; Gori A; Raviglione MC
    PLoS Med; 2022 Jan; 19(1):e1003873. PubMed ID: 35025880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accountability in the global response to HIV: measuring progress, driving change.
    Collins C; Coates TJ; Szekeres G
    AIDS; 2008 Aug; 22 Suppl 2(Suppl 2):S105-111. PubMed ID: 18641477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global drug policy at an impasse: Examining the politics of the 2016 United Nations General Assembly Special Session.
    Sischy J; Blaustein J
    Int J Drug Policy; 2018 Oct; 60():74-81. PubMed ID: 30173003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing governance models and funding mechanisms of state-civil society partnerships for HIV/AIDS treatment and prevention based on lessons from Ghana.
    Hushie M
    Afr J AIDS Res; 2019 Jul; 18(2):138-147. PubMed ID: 31282299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries.
    Lane J; Verani A; Hijazi M; Hurley E; Hagopian A; Judice N; MacInnis R; Sanford S; Zelek S; Katz A
    PLoS One; 2016; 11(2):e0146720. PubMed ID: 26914708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proposed UNGASS indicators and the monitoring of the AIDS epidemic in Brazil].
    Barbosa Junior A; Pascom AR; Szwarcwald CL; Dhalia Cde B; Monteiro L; Simão MB
    Rev Saude Publica; 2006 Apr; 40 Suppl():94-100. PubMed ID: 16729164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of national and international HIV/AIDS funding and governance mechanisms on the development of civil-society responses to HIV/AIDS in East and Southern Africa.
    Kelly KJ; Birdsall K
    AIDS Care; 2010; 22 Suppl 2():1580-7. PubMed ID: 21161762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in global blood safety for HIV.
    Takei T; Amin NA; Schmid G; Dhingra-Kumar N; Rugg D
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S127-31. PubMed ID: 19901625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-civil society partnerships for HIV/AIDS treatment and prevention in Ghana: exploring factors associated with successes and challenges.
    Hushie M; Omenyo CN; van den Berg JJ; Lally MA
    BMC Health Serv Res; 2016 Aug; 16():332. PubMed ID: 27484178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.